Problems with a DreamStation CPAP Put Man in Coma with Respiratory Failure, Lawsuit Claims

The lawsuit claims DreamStation CPAP device problems put the plaintiff in a coma for two weeks, and he spent an additional two weeks on a ventilator

An Arkansas man indicates in a recently filed lawsuit that he spent two weeks in a coma due to design problems with a DreamStation CPAP, which eventually led to a recall for millions of the sleep apnea machines, according to a product liability lawsuit.

Kenneth Engelkes filed the complaint (PDF) in Arkansas Circuit Court on July 20, alleging that the defendants Koninklijke Philips and its North American subsidiaries knew about problems with the Dreamstation CPAP, which contained a defective sound abatement foam which was prone to degrade and release chemicals and gasses directly into the machine’s air pathways.

Philips issued a massive DreamStation CPAP recall in June 2021, impacting millions of sleep apnea machines which contained the polyester-based polyurethane (PE-PUR) foam, which was intended to reduce noise and vibrations while the device was used. However, it is now known that the PE-PUR foam breaks down as the machine is used, causing particles to be inhaled or digested by the user while sleeping.

Breathing the foam particles has been linked to reports of cancers, lung damage and severe respiratory injuries, according to claims presented in hundreds of other similar Philips DreamStation CPAP lawsuits already being pursued by former users.

Stay Up-to-Date About

Philips CPAP Recall Lawsuits

AboutLawsuits.com sends a weekly digest email with information about recalls, lawsuits and warnings that may impact your family, which will include any new Philips CPAP recall lawsuit updates or developments.

"*" indicates required fields

Engelkes indicates in his lawsuit that he began using a DreamStation CPAP device in August 2018, for the treatment of sleep apnea. Just a couple months later, he was admitted to the hospital with severe respiratory disease in October 2018.

“While admitted to the hospital, Plaintiff was diagnosed with Acute Respiratory Failure with Hypoxia, Hypercapnia and Acute Kidney Failure,” the lawsuit notes. “Plaintiff spent two weeks in a coma and spent another two weeks on a ventilator.”

The lawsuit blames Engelkes’ use of the DreamStation CPAP device for causing the coma and his respiratory problems, which continue to greatly impact his life.

In addition to various state court claims filed nationwide, most of the U.S. litigation over the DreamStation CPAP problems is pending in the federal court system, where the lawsuits have been centralized before U.S. District Judge Joy Flowers Conti in the Western District of Pennsylvania for coordinated discovery and pretrial proceedings. The parties are currently engaged in common fact discovery regarding common issues raised in the DreamStation CPAP lawsuits, and are expected to select a group of representative claims to prepare for a series of early trial dates, which will help gauge how juries are likely to respond to certain evidence and testimony that will be repeated throughout the litigation.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Johnson & Johnson Faces Medical Monitoring Lawsuit Over Future Baby Powder Cancer Risks
Johnson & Johnson Faces Medical Monitoring Lawsuit Over Future Baby Powder Cancer Risks (Posted yesterday)

Women who used Johnson's Baby Powder around their genitals for feminine hygiene purposes now live in fear of developing ovarian cancer, according to the class action lawsuit seeking medical monitoring for future diagnoses

More Than 9,600 Join Suboxone Lawsuit Over Tooth Decay in MDL Filing
More Than 9,600 Join Suboxone Lawsuit Over Tooth Decay in MDL Filing (Posted 2 days ago)

A bundled complaint of about 9,600 Suboxone lawsuits were filed in federal court on Friday, ahead of the two-year anniversary of the FDA requiring tooth decay label warnings on the opioid treatment film strips, which is also a deadline for filing a civil complaint in many states.